Skip to main content
. 2021 Oct 13;12:754565. doi: 10.3389/fendo.2021.754565

Table 4.

Clinical features of the patients submitted to calcium-stimulation test with a final histological diagnosis negative for MTC.

Age, yrs Origin Ct, pg/ml proCt, ng/mL Histology (mm)
Basal Peak Basal Peak
Females
1 47 #2 11.6 623 0.05 0.12 FA+CCH
2 57 #2 15.7 279 0.05 0.05 GIA+ CCH
3 64 #2 27.7 296 0.05 0.08 GIA+CCH
4 69 #2 27.8 494 0.05 0.1 PTC
5 51 #2 8.9 188 0.05 0.07 PTC
6 59 #3 28.9 891 0.07 0.14 GIA+ CCH
7 72 #3 23.8 338 0.07 0.11 HG+ CCH
Males
1 54 #1 7.6 84.7 <0.04 0.07 FA
2 58 #1 19.4 238 0.05 0.12 HG+CCH
3 45 #1 18.4 157 <0.04 0.06 HG+ CCH
4 67 #1 22.4 414 <0.04 0.1 HG+CCH
5 57 #2 18.3 706 0.05 0.08 PTC
6 65 #3 16 341 0.06 0.19 HG+CCH

CCH, C-cells-hyperplasia; Ct, calcitonin; FA, follicular adenoma; HG, hyperplastic goiter; MTC, medullary thyroid cancer; proCt, procalcitonin; PTC, papillary thyroid cancer.